Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
The category recognizes outstanding contributions in health equity, by life science companies or public sector organizations LONDON, Feb. 17, 2025 /PRNewswire/ -- The Galien Foundation ...
In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease ... mark and design logo, CTX112 ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
7h
FOX 29 Philadelphia on MSNCHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapyThe Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
6d
Topeka WIBW-TV on MSNWeekend blood drive supports people with sickle cell diseaseThe Sickle Cell Blood Drive with the American Red Cross runs 9 a.m. to 2 p.m. Saturday at Apostolic Church of Jesus Christ, ...
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
On Tuesday, the Buffalo community came together to spread awareness about sickle cell disease during Black History Month.
Gallbladder problems are a common complication in individuals with sickle cell disease. These issues often arise due to the breakdown of red blood cells and the subsequent formation of gallstones ...
News 8 is once again honoring Black history by looking at health care and the racial disparities many report facing.
Researchers at the New York Blood Center have made a breakthrough in understanding the body’s autoimmune response to sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results